Research graph

References

References from Fosfomycin for Extended-Spectrum Beta-Lactamase Producers—Initial Monotherapy, Transition Therapy, Combination Therapy or Not at All?. Local targets link to admitted publications; unresolved targets remain external evidence.

Unresolved reference

2012 · External reference

Effect of 5-day nitrofurantoin vs single-dose fosfomycin on clinical resolution of uncomplicated lower urinary tract infection in women: a randomized clinical trial

10.1001/jama.2018.3627 · 2018 · External reference

Clinical and bacteriological effectiveness of three different short-course antibiotic regimens and single-dose fosfomycin for uncomplicated lower urinary tract infections in women (SCOUT): a pragmatic, multicentre, open-label, randomised clinical trial

10.1016/s0140-6736(25)02171-3 · 2026 · External reference

Clinical practice guideline by Infectious Diseases Society of America: 2025 guideline on management and treatment of complicated urinary tract infections–selection of antibiotic therapy for complicated urinary tract infections

10.1093/cid/ciaf460 · 2026 · External reference

Daily fosfomycin versus levofloxacin for complicated urinary tract infections

10.1128/mbio.01677-23 · 2023 · External reference

Fosfomycin as Oral Transition Therapy Versus Continued Intravenous β-Lactams for Complicated Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase–Producing Enterobacterales : A Multicenter, Open-Label, Randomized Controlled Trial

10.1093/cid/ciag345 · 2026 · Admitted local publication

Fosfomycin vs ciprofloxacin as oral step-down treatment for Escherichia coli febrile urinary tract infections in women: a randomized, placebo-controlled, double-blind, multicenter trial

10.1093/cid/ciab934 · 2022 · External reference

Antibiotic treatment for 7 versus 14 days in patients with bloodstream infections

10.1056/nejmoa2404991 · 2025 · External reference

Fosfomycin for injection (ZTI-01) versus piperacillin-tazobactam for the treatment of complicated urinary tract infection including acute pyelonephritis: ZEUS, a phase 2/3 randomized trial

10.1093/cid/ciz181 · 2019 · External reference

Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial

10.1093/jac/dkad147 · 2023 · External reference